Portola Pharmaceuticals
PTLA
$18.03
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Revenue for Portola Pharmaceuticals (PTLA)
Revenue in 2020 (TTM): $0.12 B
According to Portola Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $0.12 B. In 2019 the company made a revenue of $0.11 B an increase over the years 2018 revenue that were of $40.13 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Portola Pharmaceuticals from 2012 to 2020
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2020 (TTM) | $0.12 B | 3.62% |
| 2019 | $0.11 B | 190.66% |
| 2018 | $40.13 M | 77.99% |
| 2017 | $22.54 M | -36.5% |
| 2016 | $35.5 M | 194.15% |
| 2015 | $12.07 M | 25.39% |
| 2014 | $9.62 M | -8.6% |
| 2013 | $10.53 M | -85.38% |
| 2012 | $72.04 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 76,866.74% | 🇺🇸 USA |
 Pfizer PFE | $58.49 B | 48,300.63% | 🇺🇸 USA |
 Sanofi SNY | $50.35 B | 41,567.97% | 🇫🇷 France |
 Biogen BIIB | $9.66 B | 7,895.28% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $45.53 B | 37,575.00% | 🇺🇸 USA |